StonvexLoading…
StonvexStonvexStonvexCore line items from HSHP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $131.90M | $123.60M | $36.70M | $0.00 |
Operating Income | $68.20M | $66.70M | $14.60M | $-1.97M |
Net Income | $17.70M | $21.10M | $1.50M | $-1.95M |
EPS (Diluted) | $0.38 | $0.48 | $0.04 | $-0.06 |
Total Assets | $863.90M | $880.10M | $599.21M | $177.81M |
Total Liabilities | $702.20M | $725.40M | $445.00M | $87.49M |
Cash & Equivalents | $32.40M | $19.40M | $25.55M | $263.00K |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 46.65M | 43.90M | 43.90M | 32.15M |